Franklin Resources’s Soleno Therapeutics SLNO Stock Holding History

Franklin Resources’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-835,178	Closed	-$28M	–	3324
2026 Q1	$28M	Buy	835,178 +11,220	+1%	+$440K	0.01%	851
2025 Q4	$38.1M	Sell	823,958 -11,793	-1%	-$647K	0.01%	728
2025 Q3	$56.5M	Buy	835,751 +649,349	+348%	+$48.1M	0.01%	598
2025 Q2	$15.6M	Buy	+186,402	New	+$14M	﹤0.01%	999
2025 Q1	–	Sell	-15,000	Closed	-$674K	–	3056
2024 Q4	$674K	Buy	+15,000	New	+$777K	﹤0.01%	2162

Franklin Resources's SLNO Position: Q2 2026 in Review

Franklin Resources sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 835,178 shares — an estimated $28M sold.

Franklin Resources first reported a position in SLNO in Q4 2024 and held it in 5 quarters. The position peaked at $56.5M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Franklin Resources reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Franklin Resources sold 835,178 Soleno Therapeutics shares in Q2 2026, an estimated $28M.
Franklin Resources first reported a position in Soleno Therapeutics in Q4 2024 and held it in 5 quarters.
Franklin Resources's Soleno Therapeutics position peaked at $56.5M in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.